Trulieve Cannabis Corp. (TRLV) is a prominent player in the US cannabis market, distinguished by its comprehensive vertical integration that encompasses cultivation, production, and retail distribution of cannabis products. With a significant presence in critical states like Florida, Trulieve is dedicated to delivering high-quality and innovative solutions that cater to a diverse consumer base. The company’s robust commitment to community involvement and sustainable business practices not only enhances its brand reputation but also positions Trulieve strategically for long-term growth amidst the dynamic landscape of the cannabis industry.
| Revenue (TTM) | $1.14B |
| Gross Profit (TTM) | $677.39M |
| EBITDA | $301.02M |
| Operating Margin | 12.80% |
| Return on Equity | -47.60% |
| Return on Assets | 3.28% |
| Revenue/Share (TTM) | $5.93 |
| Book Value | $6.07 |
| Price-to-Book | 3.13 |
| Price-to-Sales (TTM) | 2.09 |
| EV/Revenue | 2.329 |
| EV/EBITDA | 6.07 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -10.30% |
| Shares Outstanding | $170.16M |
| Float | $167.89M |
| % Insiders | 1.34% |
| % Institutions | 21.40% |
Volatility is currently expanding
The marijuana industry is entering another important period for investors as September 2026 gets underway. Cannabis stocks have experienced significant volatility over the past several years. However, several major operators continue building their businesses despite challenging industry conditions.
Perpetual Royalty-Free License Covers Alien Labs and Connected Brands TALLAHASSEE, Fla., Sept. 28, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S, today announced a licensing deal with Connected for the exclusive rights to genetics, trademarks, and proprietary know-how to produce and sell Alien Labs and Connected branded cannabis products in Florida and Texas.
Cannabis stocks are entering a potentially transformative period as federal reform takes hold. Stronger business fundamentals and wider market access are reshaping the legal cannabis industry. For cannabis investors and enthusiasts, this moment represents more than short-term stock-market excitement—it reflects the gradual evolution of cannabis from a restricted market into a more established American industry.
Inclusion Marks Another Milestone as Trulieve Broadens U.S. Capital Markets Exposure TALLAHASSEE, Fla., Sept. 22, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that the company has been added to the S&P Total Market Index (TMI), S&P Completion Index (CI), and sector sub-indices S&P TMI Health Care and S&P CI Health Care.
Trulieve Cannabis Corp. is reinitiated as a Buy, driven by regulatory catalysts and attractive valuation after a recent 81% rally. Rescheduling of medicinal cannabis to Schedule III eliminates punitive tax burdens, boosts cash flows, and enables greater R&D and financing flexibility for TRLV. TRLV is well-positioned for growth through Florida consolidation, expansion into Texas and Alabama, and potential upside from a $583M tax liability reversal.
New DeKalb County location will host grand opening celebration Thursday, September 10 TALLAHASSEE, Fla., Sept. 4, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Dunwoody, Georgia.
TALLAHASSEE, Fla., Sept. 2, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced planned event participation in September.
Marijuana stock investors are watching for new market potential. With all the new laws and changes, the possibilities to make money are there. Now, much of this sector has forever been one that is almost impossible to gauge. Meaning the volatility is so high that even the best company news may not impact trading like other public companies.
TALLAHASSEE, Fla., Aug. 18, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., announced it will ring The Closing Bell® at the New York Stock Exchange (NYSE) at 4:00 P.M.
What will help marijuana stock investors trade more, even in the midst of laws changing in the USA? It is no secret that nothing has moved pot stocks more than news of global reform or regulatory matters. For the US, what happens at the federal level has moved the needle the most, with the recent passing of legislation to reclassify cannabis to Schedule 3.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on TRLV and any ticker you trade — then tracks every position and per-strategy win rate.
